Grigoris Gerotziafas: Proud Moment for Team CaVITE at EHA 2026
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”Proud Moment for Team CaVITE at European Hematology Association (EHA) 2026
Congratulations to Dr Pedro Henrique Las Casas and all members of Team CaVITE – Cancer, Vessels, Biology and Therapeutics, Sorbonne University and CRSA PARIS, for their outstanding scientific contribution presented at the EHA Congress 2026.
Poster Presentation:
Bleeding Events in Patients with Multiple Myeloma Treated with BCMA-Directed CAR T-Cell Therapy: A Systematic Review of Clinical Trials
This work addresses an increasingly important challenge in the era of cellular therapies: understanding and preventing hemorrhagic complications associated with BCMA-directed CAR-T treatments in patients with multiple myeloma.
The study provides a comprehensive synthesis of available evidence and contributes valuable insights into the safety profile of these innovative therapies, helping clinicians optimize patient management and improve outcomes.
This achievement reflects the commitment, scientific rigor, and collaborative spirit of our multidisciplinary international team, dedicated to advancing research at the intersection of hematology, thrombosis, hemostasis, vascular biology, and cancer therapeutics.
Congratulations to Pedro and all co-authors for representing CaVITE and Sorbonne University with excellence at EHA 2026.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 10:00Benjamin Tur: Putting Iron Deficiency Anemia on the Global Agenda at the Paris Peace Forum’s Child Summit
-
Nov 14, 2026, 09:48Jack Shuang Hou: FDA Approves Bayer’s Sunharbo – First Factor XIa Inhibitor for Secondary Stroke Prevention
-
Nov 14, 2026, 09:42Samwel Mikaye: What Every Patient Should Know About DVT Symptoms and Treatment
-
Nov 14, 2026, 09:37Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk – Thrombosis and Haemostasis Journal
-
Nov 14, 2026, 09:30Ney Carter Borges: Vulnerable Plaque – Imaging and Clinical Significance
-
Nov 14, 2026, 09:25Carmelo Raffo: How Much Antithrombotic Therapy is Truly Necessary after LAAC?
-
Nov 14, 2026, 09:19Mary Cushman: Excellent to Have Jordan Shavit Visit Us for a Virtual Lab Meeting Today
-
Nov 14, 2026, 09:15Chancellor Donald: Heading to ASH 2026 in New Orleans? Let’s Connect on Faculty Opportunities at Tulane
-
Nov 14, 2026, 09:11Sajja Venkatesh: FDA Approved Asundexian, the First Factor XIa Inhibitor